Australian Electric Utilities Stock News

4DMedical (ASX:4DX) is in focus after Azra AI announced an OEM and reseller partnership that links 4DMedical’s lung imaging software with Azra’s real-time patient identification platform across multiple pulmonary care pathways. See our latest analysis for 4DMedical. The Azra AI partnership comes as 4DMedical trades at A$3.79, with a 30-day share price return of 10.5% and a 90-day share price return of 15.55%, while the 1-year total shareholder return is very large and points to strong...

6K Additive, Inc. ( ASX:6KA ) is possibly approaching a major achievement in its business, so we would like to shine...

It's been a good week for Adrad Holdings Limited ( ASX:AHL ) shareholders, because the company has just released its...

Insiders who bought AU$90.0k worth of Buru Energy Limited ( ASX:BRU ) stock in the last year recovered part of their...

Transurban Group recently released its full-year 2026 results, reporting A$3,895 million in sales and A$366 million in net income, alongside a A$0.213921 per security cash dividend that went ex-dividend on 29 June 2026. The company also issued fiscal 2027 distribution guidance of A$0.72 per security, giving investors clearer visibility on expected cash returns from its toll road portfolio. We’ll now examine how Transurban’s stronger full-year profit and 2027 distribution guidance may...

Stockland walked into this result priced like a problem child, with the stock around A$4.55 and trading on a modest P/E despite a long running thesis of undervaluation. The headline today is simple. Funds From Operations, the key cash earnings metric for real estate investment trusts, landed at A$892m at the top end of guidance, while gearing sat at 22.7% and net tangible assets reached A$4.39 per security. The share price reaction now has to catch up with a year that management openly called...

Southern Cross Electrical Engineering walked into this result with the stock up roughly 17% over three months and trading at A$4.48 at Tuesday’s close. That is a price that already reflects higher expectations, with the P/S ratio above both peers and the wider Australian construction sector. The headline from the full year numbers is simple. Underlying profit surged, with underlying net profit after tax at A$39.4m and margins improving, yet statutory profit shrank to A$7.1m after a A$46.1m...

HealthCo Healthcare and Wellness REIT came into this result priced for worry, trading at A$0.72 and drifting over the past month even as the long thesis has leaned on hospital-like resilience and infrastructure style income. The headline from these FY26 numbers is not revenue or earnings per share. It is cash flow and distributions. Funds from operations, the key measure for real estate investment trusts, was reported at A$0.04 per unit, while underlying look through funds from operations...

BlueScope Steel earnings jump puts North America in focus BlueScope Steel (ASX:BSL) is in the spotlight after reporting full year 2026 earnings, with net income of A$802 million and sales of A$16.7b, alongside management emphasis on North American demand. See our latest analysis for BlueScope Steel. BlueScope Steel's A$32.15 share price has had a choppy few weeks, with the share price return down 6.9% over 7 days but still up 33.2% year to date and supported by a 45.2% total shareholder...

SHAPE Australia stock was treading water coming into the result, with only a small move over the past week and a mixed 12 month share price path. The headline today is that the earnings story looks far stronger than the recent share price mood suggests. Full year revenue reached about A$1.20b and net profit after tax came in at A$31.7m, with earnings per share at A$0.38 on a trailing 12 month view. The real hook for investors is margin. Management focused on higher margin work and operating...

As the Australian market opens slightly lower following declines in US indices and rising oil prices, investors are keenly observing how these global dynamics might influence local stocks. In this environment, identifying undervalued stocks such as Cogstate on the ASX can offer potential opportunities for investors seeking to capitalize on discrepancies between a company's market price and its intrinsic value.

The Australian market is poised for a cautious start today, influenced by recent declines in US markets and rising oil prices due to geopolitical tensions. In such a fluctuating landscape, investors often seek opportunities beyond the well-trodden paths of blue-chip stocks. Penny stocks, though considered a somewhat outdated term, continue to attract attention for their potential growth at lower price points. These smaller or newer companies can offer significant value when they possess...

Healius walked into these results trading at A$0.42 with flat performance over the past week and modest gains over the past three months. The stock carries a reputation as a deep value healthcare play. Today’s headline is not about a revenue story. It is about a large hit to equity value and rising leverage. The company booked a sizeable goodwill impairment of A$332m and shifted from net cash of A$57.2m to net debt of A$32.8m. That combination sharpened the focus on the balance sheet and on...

Wagners Holding closed at A$4.20 on Wednesday, only slightly lower over the past week, which suggests investors are still weighing what a much stronger year really means for the stock. The headline is simple. Earnings growth has been powerful, net profit margin has lifted to 8% and the stock trades on a P/E of 20.7x that is well below its listed peers yet above the broader Global Basic Materials average. For anyone thinking beyond today’s price flicker, that mix of higher profitability and a...

Hansen Technologies closed at A$3.35 today after a rough run that left the stock down about 31% over three months. The earnings print itself told a calmer story. Revenue for FY26 sat near A$390.0m while underlying EBITDA reached about A$120.0m with a margin near 31%. That combination lifted net profit margins to 12.2%. The market is trading the stock as if the past weakness is the whole picture. The headline from these numbers is a software business squeezing more profit from largely flat top...

Service Stream stock closed at A$2.61 after the market had a full day to digest yesterday’s FY26 result. The share price has already climbed 4.4% over the past week and 13.9% over three months, yet the real story sits in the earnings quality behind that move. The headline this time is margin and profit strength. Earnings before interest, tax, depreciation and amortisation reached A$163.4m with a 6.6% margin and adjusted net profit after tax came in at A$81.1m. That is what now frames the long...

In August 2026, Charter Hall Retail REIT reported full-year 2026 results showing A$174.6 million in sales and A$389.4 million in net income, and issued 2027 guidance for earnings of at least A$0.273 per unit and distributions of at least A$0.264 per unit, each implying minimum 3.5% growth on 2026. The combination of higher profit and earnings per unit despite lower sales, alongside firm distribution guidance, highlights management’s confidence in the REIT’s income resilience and cost...

Cogstate came into this result with the stock at A$2.93 and a solid double digit return over the past three months, so expectations were already warm. The headline today is simple: this is a revenue and margin story. Full year revenue reached about US$60.9m and earnings from continuing operations were about US$11.9m, which puts the reported net margin near 19.5%. The bigger hook for you as an investor is forward visibility, with management highlighting a sharp jump in new contracts and a...

Region Group walked into this result with a stock that has been drifting lower, down about 6% over the past week and 4% over the past month, even before investors fully absorbed the details. The headline is that funds from operations, the key cash earnings measure for a real estate investment trust, held up and management put numbers around FY27 guidance, yet that caution in the share price suggests investors remain unconvinced. The real tension sits between a solid A$184.7m of trailing funds...

Amaero closed at A$0.22 today after a volatile year that left the stock down about 17% over the past month and 33% over three months. The headline from this earnings release is clear: revenue for FY 2026 reached A$18.1m with a record A$7.8m quarter, yet the company still reported sizeable losses and a stretched balance sheet. The tension for investors is now about time horizon. In the short term, the stock is pricing in pressure around ongoing losses, cash runway and a rich P/S multiple. The...

Challenger stock closed at A$9.80 on Wednesday, barely changed over the past week, which signals a market that is still undecided. That muted reaction sits against an earnings story built around one thing that matters most right now: profit quality. Normalized net profit after tax came in at A$468m and normalized return on equity reached 11.6%, both backed by a 16.4% net margin on the latest trailing twelve month numbers. The question for you is whether a flat share price really reflects that...

Lottery closed at A$5.36 on Wednesday, with the share price under mild pressure over the past month even before investors processed the full FY26 story. The headline is margin strain. Trailing net profit margin has slipped to 8% from 9.7% a year earlier, while the stock still trades on a rich P/E of 41.9x compared with a Global Hospitality industry average of 18.8x. For short term traders, that mix of softer profitability and premium valuation can sting. Long term holders will focus more on...

Judo Capital Holdings closed at A$1.015 on Wednesday, only modestly higher over the past month and still well below where the stock traded earlier this year. The market has priced in recent volatility. The latest FY26 earnings convey a different message. Net profit after tax reached A$111.1m and the net interest margin improved to 3.13%, supported by a cost to income ratio now in the mid 40s. For a specialist business lender, that margin and efficiency story is the key point, with the share...

Pro Medicus walked into these results with its stock already on a tear, up sharply over the past three months and closing at A$198.85 on 19 August. The market has been paying a rich multiple for perfection. The headline from this earnings release is simple: profitability remains extremely high, with net profit margin at 54.1%, yet the valuation now sits on a trailing P/E of 78.3x that leans heavily on non cash earnings. That is the sentiment clash investors need to solve: enthusiasm for the...